Analysis of pulmonary surfactant in rat lungs after inhalation of nanomaterials: Fullerenes, nickel oxide and multi-walled carbon nanotubes

Nanotoxicology

Volumn 10, Issue 2, 2016, Pages 194-203

  Kadoya, Chikara ^a   Lee, Byeong Woo ^a   Ogami, Akira ^a   Oyabu, Takako ^a   Nishi, Ken Ichiro ^a   Yamamoto, Makoto ^a   Todoroki, Motoi ^a   Morimoto, Yasuo ^a   Tanaka, Isamu ^a   Myojo, Toshihiko ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

C60; inhalation; MWCNTs; phospholipid; pulmonary surfactant; SP D

Indexed keywords

FULLERENE DERIVATIVE; LUNG SURFACTANT; MULTI WALLED NANOTUBE; NANOMATERIAL; NICKEL NANOPARTICLE; PHOSPHOLIPID; PROTEIN; SURFACTANT PROTEIN D; AEROSOL; CARBON NANOTUBE; NANOPARTICLE; NICKEL; NICKEL MONOXIDE;

AEROSOL; ANIMAL TISSUE; ARTICLE; BRONCHOALVEOLAR LAVAGE FLUID; CONTROLLED STUDY; EXPOSURE; INHALATION; LUNG; NEUTROPHIL; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; RAT; RETROSPECTIVE STUDY; SURFACE TENSION; ANIMAL; DRUG EFFECTS; MALE; METABOLISM; PATHOLOGY; TOXICITY; WISTAR RAT;

AEROSOLS; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; FULLERENES; INHALATION EXPOSURE; LUNG; MALE; NANOPARTICLES; NANOTUBES, CARBON; NICKEL; PHOSPHOLIPIDS; PROTEINS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; PULMONARY SURFACTANTS; RATS; RATS, WISTAR; SURFACE TENSION;

EID: 84959367038     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2015.1039093     Document Type: Article

References (34)

1. Baker GL, Gupta A, Clark ML, Valenzuela BR, Staska LM, Harbo SJ, et al. 2008. Inhalation toxicity and lung toxicokinetics of C60 fullerene nanoparticles and microparticles. Toxicol Sci 101: 122-31
2. Brook RD, Rajagopalan S, Pope CA, Brook JR, Bhatnagar A, Diez-Roux AV, et al. 2010. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation 121: 2331-78
3. Cogo PE, Simonato MS, Danhaive O, Verlato G, Cobellis G, Savignoni F, et al. 2013. Impaired surfactant protein B synthesis in infants with congenital diaphragmatic hernia. Eur Respir J 41: 677-82
4. Delorme MP, Muro Y, Arai T, Banas DA, Frame SR, Reed KL, Warheit DB. 2012. Ninety-Day inhalation toxicity study with a vapor grown carbon nanofiber in rats. Toxicol Sci 128: 449-60
5. Elder A, Gelein R, Silva V, Feikert T, Opanashuk L, Carter J, et al. 2006. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect 114: 1172-8
6. Han SG, Andrews R, Gairola CG. 2010. Acute pulmonary response of mice to multi-wall carbon nanotubes. Inhal Toxicol 22: 340-7
7. Henderson RF. 2005. Use of bronchalveolar lavage to detect respiratory tract toxicity of inhaled material. Exp Toxicol Pathol 57: 155-9
8. ICRP. 1994. Publication 66, Human Respiratory Tract Model for Radiological Protection. Oxford: Pergamon Press
9. Kadoya C, Ogami A, Morimoto Y, Myojo T, Oyabu T, Nishi K, et al. 2011. Analysis of bronchoalveolar lavage fluid adhearing to lung surfactant. Ind Health 50: 31-6
10. Kasai T, Gotoh K, Nishizawa T, Sasaki T, Katagiri T, Umeda Y, et al. 2014. Development of a new multi-walled carbon nanotube (MWCNT) aerosol generation and exposure system and confirmation of suitability for conducting a single-Exposure inhalation study of MWCNT in rats. Nanotoxicology 8: 169-78
11. Kuroda K, Morimoto Y, Ogami A, Oyabu T, Nagatomo H, Hirohashi M, et al. 2006. Phospholipid concentration in lung lavage fluid as biomarker for pulmonary fibrosis. Inhal Toxicol 18: 389-93
12. Kuroki Y, Tsutahara S, Shijubo N, Takahashi H, Shiratori M, Hattori A, et al. 1993. Elevated levels of lung surfactant protein A in sera from patients with idiopathic pulmonary fibrosis and pulmonary alveolar proteinosis. Am Rev Respir Dis 147: 723-9
13. Lee BW, Kadoya C, Horie M, Mizuguchi Y, Hashiba M, Kambara T, et al. 2013. Analysis of pulmonary surfuctant in rat lungs after intratracheal instillation of short and long multi-walled carbon nanotubes. Inhal Toxicol 25: 609-20
14. Ma-Hock L, Treumann S, Strauss V, Brill S, Luizi F, Mertler M, et al. 2009. Inhalation toxicity of multi-wall car bon nanotubes in rats exposed for three months. Toxicol Sci 112: 468-81
15. Mizuguchi Y, Myojo T, Oyabu T, Hashiba M, Lee BW, Yamamoto M, et al. 2013. Comparison of dose-response relations between 4-week inhalation and intratracheal instillation of NiO nanoparticles using polimorphonuclear neutrophils in bronchoalveolar lavage fluid as a biomarker of pulmonary inflammation. Inhal Toxicol 25: 29-36
16. Morimoto Y, Hirohashi M, Ogami A, Oyabu T, Myojo T, Nishi K, et al. 2010. Inflammogenic effect of well-characterized fullerenes in inhalation and intratracheal instillation studies. Particle Fibre Toxicol 7: 4
17. Morimoto Y, Hirohashi M, Ogami A, Oyabu T, Myojo T, Todoroki M, et al. 2011. Pulmonary toxicity of well-Dispersed multi-wall carbon nanotubes following inhalation and intratracheal instillation. Nanotoxicology 6: 587-99
18. Murata M, Otsuka M, Mizuno H, Shiratori M, Miyazaki S, Nagae H, et al. 2010. Development of an enzyme-linked immunosorbent assay for measurement of rat pulmonary surfactant protein D using monoclonal antibodies. Exp Lung Res 36: 463-8
19. Murphy FA, Poland CA, Duffin R, Donaldson K. 2013. Length-Dependent pleural inflammation and parietal pleural responses after deposition of carbon nanotubes in the pulmonary airspaces of mice. Nanotoxicology 7: 1157-67
20. Nakanishi J. 2011. Risk assessment of manufactured nanomaterials: "Approaches"-overview of approaches and results. Final report issued on August 17, NEDO Project (P06041) "Research and development of nanoparticle characterization methods". Available at: http://www.aist-riss.jp/projects/nedo-nanorisk/nano-rad2/docs/ES-20130222e.zip
21. Oberdörster G, Ferin J, Gelein R, Soderholm SC, Finkelstein J. 1992. Role of the alveolar macrophage in lung injury: studies with ultrafine particles. Environ Health Perspect 97: 193-9
22. Oberdörster G, Ferin J, Lehnert BE. 1994. Correlation between particle size, in vivo particle persistence, and lung injury. Environ Health Perspect 102: 173-9
23. Ogami A, Yamamoto K, Morimoto Y, Fujita K, Hirohashi M, Oyabu T, et al. 2011. Pathological features of rat lung following inhalation and intratracheal instillation of C60 fullerene. Inhal Toxicol 23: 407-16
24. Oyabu T, Myojo T, Morimoto Y, Ogami A, Hirohashi M, Yamamoto M, et al. 2011. Biopersistence of inhaled MWCNT in rat lungs in a 4-week well-characterized exposure. Inhal Toxicol 23: 784-91
25. Park EJ, Kim H, Kim Y, Yi J, Choi K, Park K. 2010. Carbon fullerenes(C60) can induce inflammatory responses in the lung of mice. Toxicol Appl Pharmacol 244: 226-33
26. Sayes CM, Marchione AA, Reed KL, Warheit DB. 2007. Comparative pulmonary toxicity assessments of C60 water suspensions in rats: few differences in fullerene toxicity in vivo in contrast to in vitro profiles. Nano Lett 7: 2399-406
27. Schurch S, Goerke J, Clements JA. 1976. Direct determination of surface tension in the lung. Proc Natl Acad Sci USA 73: 4698-702
28. Schleh C, Hohlfeld JM. 2009. Interaction of nanoparticles with the pulmonary surfactant system. Inhal Toxicol 21: 97-103
29. Shimada M, Wang WN, Okuyama K, Myojo T, Oyabu T, Morimoto Y, et al. 2009. Development and evaluation of an aerosol generation and supplying system for inhalation experiments of manufactured nanoparticles. Environ Sci Technol 43: 5529-34
30. Shinohara N, Nakazato T, Tamura M, Endoh S, Fukui H, Morimoto Y, et al. 2010. Clearance kinetics of fullerene C 60 nanoparticles from rat lungs after intratracheal C 60 instillation and inhalation C 60 exposure. Toxicol Sci 118: 564-73
31. Takahashi H, Fujishima T, Koba H, Murakami S, Kurokawa K, Shibuya Y, et al. 2000. Serum surfactant proteins A and D as prognosis factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med 162: 1109-14
32. The Japan Society for Occupational Health. 2013. Recommendation of occupational exposure limits (2013-2014). J Occup Health 55: 422-41
33. Whitsett JA, Weaver TE. 2002. Hydrophobic surfactant proteins in lung function and disease. N Eng J Med 347: 2141-8
34. Wright JR. 2005. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 5: 58-68